Epigallocatechin gallate: all 43 studies that test it
Page 1 of 1. Open to participants first (8), then studies with results posted, then the rest; newest registration first within each.
- Effectiveness of Epigallocatechin-3-Gallate (Green Tea Extract) as Adjunctive Locally Delivered Nanotherapeutic in the Treatment of Stage II PeriodontitisRecruitingNCT07754253Phase 1
- Effect of EGCG, Folic Acid, Vitamin B12 and Hyaluronic Acid on HPV DNA IntegrationNot yet recruitingNCT07697196Not applicable
- Effect of a Herbal Intracanal Medication On Postoperative Pain And Flare up Incidence In Non Surgical Root Canal RetreatmentNot yet recruitingNCT07578311Not applicable
- Curcumin and EGCG Supplementation to Improve Serum BDNF and Mood DisturbanceRecruitingNCT06531863Early Phase 1
- EGCG for the Prevention and Treatment of TIPNRecruitingNCT06524609Phase 1/2
- EGCG for Hepatocellular Carcinoma ChemopreventionRecruitingNCT06015022Phase 2
- Oxygen Atomizing Inhalation of EGCG in the Treatment Interstitial Pneumonia in Cancer PatientsRecruitingNCT05758571Phase 1/2
- Vitamin D, Epigallocatechin Gallate, D-chiro-inositol and Vitamin B6 in Uterine FibroidRecruitingNCT05448365Not applicable
- Reducing Frailty for Older Cancer Survivors Using SupplementsCompletedNCT04553666Phase 2Results posted
- Fibroblast Specific Inhibition of LOXL2 and TGFbeta1 Signaling in Patients With Pulmonary Fibrosis.CompletedNCT03928847Early Phase 1Results posted
- Effects of Epigallocatechin Gallate (EGCG) in Healthy, Young AdultsCompletedNCT00981292Phase 4Results posted
- Study of of Oxygen Nebulized Inhalation EGCG in Cancer Patients With New Coronary PneumoniaCompletedNCT06924749Phase 2
- Collagen-targeted Positron Emission Tomography (PET) Imaging for Assessment of EGCG EffectCompletedNCT06265532Phase 1
- Reducing Frailty for Older Cancer Survivors Using Supplements IISuspendedNCT06068543Phase 2
- The Study of Quadruple Therapy Quercetin, Zinc, Metformin, and EGCG as Adjuvant Therapy for Early, Metastatic Breast Cancer and Triple-negative Breast Cancer, a Novel MechanismStatus unknownNCT05680662Early Phase 1
- Study of Oral Epigallocatechin-3-gallate (EGCG) in IPF PatientsCompletedNCT05195918Phase 1
- Prevention of Cognitive Decline in ApoE4 Carriers With Subjective Cognitive Decline After EGCG and a Multimodal InterventionCompletedNCT03978052Not applicable
- Impact of Ketone Bodies and Epigallocatechin Gallate in Multiple SclerosisCompletedNCT03740295Phase 2
- Epigallocatechin Gallate Lowers Circulating Catecholamine Concentrations and Alters Lipid Metabolism.CompletedNCT03199430Phase 4
- Chemopreventive Effects of Epigallocatechin Gallate (EGCG) in Colorectal Cancer (CRC) PatientsCompletedNCT02891538Early Phase 1
- Effect of Epigallocatechin -3-gallate Supplementation in Traumatic Brain Injury PatientsCompletedNCT02731495Phase 2/3
- Study of Epigallocatechin-3-gallate (EGCG) for Skin Prevention in Patients With Breast Cancer Receiving Adjuvant RadiotherapyStatus unknownNCT02580279Phase 2
- Study of Epigallocatechin-3-gallate (EGCG) for Esophagus Protection in Patients With Lung Cancer Receiving Radial RadiotherapyStatus unknownNCT02577393Phase 2
- Epigallocatechin Gallate (EGCG) to Improve Cognitive Performance in Foetal Alcohol Syndrome (FAS) ChildrenCompletedNCT02558933Not applicable
- The Effect of Extract of Green Tea on Obese Women and Obese Related Hormone PeptidesStatus unknownNCT02147041Phase 2/3
- A Trial for the Treatment of Cardiac AL-Amyloidosis With the Green Tea Compound Epigallocatechin-3-gallate (TAME-AL)CompletedNCT02015312Phase 2
- "Using Epigallocatechin Gallate (EGCG) and Cognitive Training to Modulate Cognitive Performance in Patients With Fragile X Syndrome" (TESFX)CompletedNCT01855971Phase 2
- Normalization of dyrk1A and APP Function as an Approach to Improve Cognitive Performance and Decelerate AD Progression in DS Subjects: Epigallocatechin Gallate as Therapeutic ToolCompletedNCT01699711Phase 2
- Improvement of Endothelial Function by EGCGCompletedNCT01662232Not applicable
- Epigallocatechingallate (EGCG) in Cardiac AL AmyloidosisTerminatedNCT01511263Phase 2
- Study of Topically Applied Green Tea Extract for Radio Dermatitis and Radiation MucositisStatus unknownNCT01481818Phase 1/2
- Metabolic Effects of a Green Tea Extract in Multiple Sclerosis PatientsCompletedNCT01417312Not applicable
- Egcg, a dyrk1a Inhibitor as Therapeutic Tool for Reversing Cognitive Deficits in Down Syndrome Individuals.CompletedNCT01394796Phase 2
- Effects of EGCG (Epigallocatechin Gallate) in Huntington's Disease (ETON-Study)CompletedNCT01357681Phase 2
- Green Tea Extract: a Non-Surgical Alternative for Treatment of Uterine FibroidsTerminatedNCT01311869Phase 2
- Sunphenon Epigallocatechin-Gallate (EGCg) in Duchenne Muscular DystrophyCompletedNCT01183767Phase 2/3
- Phase I Chemoprevention Trial With Green Tea Polyphenon E & Erlotinib in Patients With Premalignant Lesions of the Head & NeckCompletedNCT01116336Phase 1
- Sunphenon EGCg (Epigallocatechin-Gallate) in the Early Stage of Alzheimer´s DiseaseCompletedNCT00951834Phase 2/3
- Efficacy and Safety Study of EGCG/Tocotrienol in 18 Patients With Splicing-mutation-mediated Cystic Fibrosis (CF)CompletedNCT00889434Not applicable
- The Role of Tea Catechins and Caffeine in Relation to Energy MetabolismCompletedNCT00611416Not applicable
- Sunphenon Epigallocatechin-gallate (EGCg) in Relapsing-remitting Multiple Sclerosis (SuniMS Study)CompletedNCT00525668Phase 1/2
- Effect of Epigallocatechin-Gallate on Inner Retinal Function in Ocular Hypertension and Early GlaucomaStatus unknownNCT00476138Phase 1/2
- Effect of EGCG on the Body's Response to InsulinWithdrawnNCT00434499Phase 2